Subscribe
Nasopharyngeal carcinoma
Can nasopharyngeal carcinoma be treated?
Nasopharyngeal carcinoma is a common clinical disease, especially in the southern regions of China. It primarily affects the nasal area as a malignant tumor. The clinical treatment outcomes for nasopharyngeal carcinoma are relatively good, and it is also referred to as "fortunate cancer," which implies that it has a relatively high cure rate. The main clinical treatment involves radiation therapy combined with chemotherapy, often described as the "sandwich" treatment method. Any tumor can be cured if detected early, and the early detection rate of nasopharyngeal carcinoma is relatively high. Therefore, its cure rate is also relatively high compared to other major organ tumors such as liver and lung cancers, which exhibit relatively lower cure rates and outcomes.
Is nasopharyngeal cancer hereditary?
Nasopharyngeal carcinoma is a malignant tumor of the nasopharynx, primarily found in regions populated by Mongoloid races, and is particularly common in coastal areas or in Guangdong and Guangxi regions. Nasopharyngeal carcinoma has a genetic component, meaning if you have a family history of this cancer, your chances and your descendants' chances of developing nasopharyngeal carcinoma are higher compared to those without such a family history. However, having a family history does not guarantee the development of nasopharyngeal carcinoma, nor does the absence of a family history ensure one will not get it. Under such circumstances, patients with a family history should regularly check their nasopharynx and consider whether there are traces of blood in the first sputum they cough up in the morning, which might indicate a malignancy in the nasopharynx. In such cases, performing a nasopharyngoscopy can generally clarify the presence or absence of a tumor.
What is nasopharyngeal carcinoma?
Nasopharyngeal carcinoma is a relatively common malignant tumor in the nasopharyngeal area, and the main pathological type is predominantly squamous carcinoma, most of which are poorly differentiated squamous carcinomas, constituting the most common malignant tumor in the nasopharyngeal area. Currently, the primary treatment option is radiotherapy, which is the most important; some patients may need to consider concurrent or adjuvant chemotherapy. If drug and radiotherapy treatments are ineffective, or if there is cervical lymph node metastasis, and for some patients where chemoradiotherapy fails with residual lesions, surgery may be considered. However, currently, the surgical treatment approach is generally not very mature and is somewhat controversial, thus it requires treatment at major hospitals.
Early symptoms of nasopharyngeal carcinoma
The symptoms of nasal cancer can be numerous. In the early stages, symptoms might not be apparent because the area affected is relatively small, which can make the symptoms unclear. Possible symptoms include bloody nasal discharge and poor nasal airflow. Some patients might experience a foreign body sensation in the nasopharyngeal area. The most important thing, however, is to use diagnostic aids to make an assessment. This can include a nasopharyngoscopy, an enhanced CT of the nasopharynx, or an enhanced MRI to preliminarily determine the presence of a tumor. If a tumor is suspected, it is possible to consider performing a biopsy and lab tests under endoscopy. Only after completing the biopsy and lab tests can it be confirmed whether it is nasopharyngeal cancer, and then further treatment plans can be considered.
What tests are done for nasopharyngeal carcinoma?
The examination items for nasopharyngeal carcinoma are mainly divided into three types. The first type is imaging examinations, the second type is blood tests, and the third type is endoscopic pathological biopsy. Imaging examinations mainly involve CT or MRI of the nasopharynx and the whole body. If necessary, PET-CT may also be considered to clarify the extent of the condition and determine the presence of neck or distant metastases, which is helpful for diagnosis and adjuvant therapy. The second type involves blood tests, mainly including general biochemical blood tests and virus detection, which can assess the basic functional status of the body. The third type is the endoscopic pathological biopsy, which involves performing a pathological biopsy under nasal endoscopy, primarily to confirm the diagnosis and observe the extent of the lesion in the nasopharynx.
Can nasopharyngeal carcinoma be treated with surgery?
Nasopharyngeal cancer is a malignant tumor in the nasopharynx, which is mainly found in coastal and Guangdong areas, and is more common among Mongoloid races. The treatment methods for nasopharyngeal cancer include radiotherapy, chemotherapy, and combined chemoradiotherapy. If the tumor does not disappear after combined chemoradiotherapy and is insensitive to drugs, surgery can be considered. Surgery is not the first-line treatment option for nasopharyngeal cancer; the first-choice treatments are radiotherapy and combined chemoradiotherapy, which are very effective and have a high five-year survival rate. If the cancer is insensitive to radiation and drugs, surgical treatment can be an option in such cases.
Do people with nasopharyngeal carcinoma lose weight?
Some patients with nasopharyngeal carcinoma may experience weight loss, but individual differences exist. This is somewhat related to the condition itself as well as to the individual's resistance and their baseline physical fitness. If the condition is detected early and the clinical symptoms are not particularly obvious, most patients will not show significant weight loss, and many people may not have noticeable symptoms. If the condition is severe, and diet and nutrition are not properly managed in a timely manner, patients may experience weight loss, especially in advanced stages of the illness. This can result in a cachectic-like state, which poses greater challenges for treatment. It is necessary to seek medical attention promptly, assess the physical condition, and consider the need for radiotherapy and chemotherapy.
Distinction between Nasopharyngitis and Nasopharyngeal Carcinoma
Nasopharyngitis and nasopharyngeal carcinoma have fundamental differences. Nasopharyngitis is an inflammatory disease, while nasopharyngeal carcinoma is a malignant tumor disease. Clinically, nasopharyngitis mainly presents with increased secretions in the nasopharyngeal area, sometimes with a slight amount of bloody secretions, but this is extremely rare. On the other hand, nasopharyngeal carcinoma primarily shows symptoms such as the proliferation of malignant tumor tissues in the nasopharynx, enlargement of the lymph nodes in the neck, headaches, and ear stuffiness. In terms of treatment, nasopharyngitis is primarily treated with medications, such as traditional Chinese medicines, nasal sprays, and nasal corticosteroids; whereas nasopharyngeal carcinoma is primarily treated with radiotherapy combined with chemotherapy, which is currently the common sandwich therapy. Overall, there are fundamental differences between the two.
Can nasopharyngeal cancer be cured?
A portion of nasopharyngeal carcinoma patients can meet the criteria for clinical cure. It largely depends on the specific staging and type of the cancer. Patients with higher differentiation and earlier stages, especially stages one and two, tend to have better treatment outcomes. Currently, radiation therapy is the primary treatment, and some patients may also need to undergo chemotherapy. Overall, chemotherapy is quite effective for most patients. However, whether clinical cure can be achieved primarily depends on the extent of the disease and individual differences. Some people respond better to radiotherapy and chemotherapy, which in turn increases their chances of clinical cure. The five-year survival rate is considered the most important indicator.
Nasopharyngeal carcinoma clinical manifestations
Nasopharyngeal carcinoma is the most common malignant tumor in the nasopharyngeal area, and clinically, it is primarily squamous cell carcinoma. The incidence of nasopharyngeal carcinoma is particularly high in the southern regions of China, especially in Guangdong. Initially, nasopharyngeal carcinoma manifests locally as a tumorous mass in the nasopharyngeal area, often with ulceration on the surface. This can lead to the presence of blood in nasal mucus, known as bloody nasal discharge. As the disease progresses, there can be swelling of the cervical lymph nodes, primarily involving the upper deep cervical lymph nodes, with about 60% of patients experiencing this type of lymph node enlargement. As the tumor enlarges, it may block the nasal passage, leading to persistent nasal congestion. The tumor's pressure on the Eustachian tube can cause symptoms of secretory otitis media. Furthermore, damage to the skull base by the tumor can lead to severe headaches. As a malignant tumor, the cancer can cause systemic symptoms such as malnutrition and cachexia. In advanced stages, metastatic symptoms may appear, such as bone and liver metastases, affecting these vital organs.